In an area with pyrethroid resistant malaria vectors with both kdr target site and P450-based metabolic mechanisms, PermaNet® 3.0 and Olyset® Plus (LLINs with PBO) can provide additional protection in terms of reduction in blood feeding and increase in mosquito mortality, compared to a pyrethroid-only net. Here, CYP2B6 is linked to malaria.